Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell Lymphoma

Bull Exp Biol Med. 2019 May;167(1):150-153. doi: 10.1007/s10517-019-04480-6. Epub 2019 Jun 10.

Abstract

In diffuse large B-cell lymphoma, bone marrow involvement is rarely diagnosed. We compared the properties of bone marrow stromal progenitor cells and the concentration of fibroblast CFU in patients with diffuse large B-cell lymphoma without bone marrow involvement and in healthy donors. It was found that the properties of multipotent mesenchymal stromal cells in patients in the debut of the disease differed considerably from those in healthy donors. In particular, the total cell production in patients was significantly higher than in donors. In multipotent mesenchymal stromal cells of patients, some cell parameters were changes; the mean fluorescence intensity of the adhesion molecule ICAM1 on the cell surface was increased. The mean fluorescence intensity of mesenchymal stromal cell markers (HLA-ABC, CD73 and CD90) was significantly elevated. The relative expression of BMP4, MMP2, FGFR1, and ICAM1 genes in mesenchymal stromal cell was reduced, while the expression of FGFR2 gene was enhanced. Despite the absence of proven involvement of the bone marrow, the properties of mesenchymal stromal cells, the components in the stromal microenvironment niche regulating hemopoiesis are altered in patients with diffuse large B-cell lymphoma.

Keywords: fibroblast colony-forming units; mean fluorescence intensity; multipotent mesenchymal stromal cells; relative level of gene expression.

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Cells / metabolism
  • Bone Marrow Cells / pathology*
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone Morphogenetic Protein 4 / metabolism
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Female
  • HLA-DR Antigens / metabolism
  • Humans
  • Intercellular Adhesion Molecule-1 / metabolism
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Male
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / pathology*
  • Middle Aged
  • Receptor, Fibroblast Growth Factor, Type 1 / metabolism

Substances

  • BMP2 protein, human
  • BMP4 protein, human
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 4
  • HLA-DR Antigens
  • ICAM1 protein, human
  • Intercellular Adhesion Molecule-1
  • Receptor, Fibroblast Growth Factor, Type 1